Sales 2024 * | 48.96B 45.44B 3,912B | Sales 2025 * | 50.79B 47.14B 4,058B | Capitalization | 203B 189B 16,255B |
---|---|---|---|---|---|
Net income 2024 * | 10.5B 9.74B 839B | Net income 2025 * | 12.07B 11.2B 965B | EV / Sales 2024 * | 4.42 x |
Net Debt 2024 * | 12.88B 11.95B 1,029B | Net Debt 2025 * | 11.28B 10.47B 901B | EV / Sales 2025 * | 4.23 x |
P/E ratio 2024 * |
19.7
x | P/E ratio 2025 * |
16.9
x | Employees | 76,057 |
Yield 2024 * |
3.62% | Yield 2025 * |
3.76% | Free-Float | 85.22% |
Latest transcript on Novartis AG
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 31/12/04 | |
Director of Finance/CFO | 59 | 31/12/02 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 15/05/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 31/12/12 |
Simon Moroney
BRD | Director/Board Member | 65 | 27/02/20 |
Chairman | 68 | 31/12/12 |
1st Jan change | Capi. | |
---|---|---|
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
-9.08% | 198B | |
+8.62% | 165B | |
+3.81% | 125B |